Overview
Timothy Pasowicz is a primary care provider, practicing in Internal Medicine in Overland Park, Kansas. Dr. Pasowicz is rated as an Experienced provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 1. His top areas of expertise are Sitosterolemia, Infant Hyperglycemia, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Pasowicz is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4061 Indian Creek Pkwy, Overland Park, KS 66207
Quivira Internal Medicine Inc
Shazia Walijan-Munir is a primary care provider, practicing in Internal Medicine in Overland Park, Kansas. Dr. Walijan-Munir is rated as an Advanced provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 1. Her top areas of expertise are Sitosterolemia, High Cholesterol, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Walijan-Munir is currently accepting new patients.
Prime Healthcare Kansas City - Physician Services LLC
Karla Houston-Gray is a primary care provider, practicing in Internal Medicine in Kansas City, Missouri. Dr. Houston-Gray is rated as an Advanced provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 1. Her top areas of expertise are Rabson-Mendenhall Syndrome, Vitamin D Deficiency, Familial Hypertension, and Hypertension. Dr. Houston-Gray is currently accepting new patients.
Statland Medical Group LLC
Nidal Boutros is a primary care provider, practicing in Internal Medicine in Overland Park, Kansas. Dr. Boutros is rated as an Advanced provider by MediFind in the treatment of Progressive Familial Intrahepatic Cholestasis Type 1. His top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Maturity Onset Diabetes of the Young. Dr. Boutros is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial HypertensionDr. Pasowicz isAdvanced. Learn about Familial Hypertension.
- Glucocorticoid-Remediable Aldosteronism
- HypertensionDr. Pasowicz isAdvanced. Learn about Hypertension.
- Infant HyperglycemiaDr. Pasowicz isAdvanced. Learn about Infant Hyperglycemia.
- SitosterolemiaDr. Pasowicz isAdvanced. Learn about Sitosterolemia.
- Experienced
- Allergic RhinitisDr. Pasowicz isExperienced. Learn about Allergic Rhinitis.
- AnemiaDr. Pasowicz isExperienced. Learn about Anemia.
- AtherosclerosisDr. Pasowicz isExperienced. Learn about Atherosclerosis.
- Bacterial ProstatitisDr. Pasowicz isExperienced. Learn about Bacterial Prostatitis.
- Biliary HypoplasiaDr. Pasowicz isExperienced. Learn about Biliary Hypoplasia.
- BRCA Positive Breast CancerDr. Pasowicz isExperienced. Learn about BRCA Positive Breast Cancer.